EGR2, affinity purified antibody, goat, 100 ug.
- Known as:
- EGR2, antigenic enriched (anti-), caprine, 100 ug.
- Catalog number:
- GT41010-100
- Product Quantity:
- 1
- Category:
- -
- Supplier:
- Neuromi
- Gene target:
- EGR2 affinity purified antibody goat 100 .
Related genes to: EGR2, affinity purified antibody, goat, 100 ug.
- Gene:
- EGR2 NIH gene
- Name:
- early growth response 2
- Previous symbol:
- KROX20
- Synonyms:
- -
- Chromosome:
- 10q21.3
- Locus Type:
- gene with protein product
- Date approved:
- 1988-08-31
- Date modifiied:
- 2019-04-23
Related products to: EGR2, affinity purified antibody, goat, 100 ug.
Related articles to: EGR2, affinity purified antibody, goat, 100 ug.
- [This retracts the article DOI: 10.3389/fcell.2020.579236.]. - Source: PubMed
Publication date: 2026/05/22
- Papillary thyroid carcinoma (PTC) exhibits marked clinical heterogeneity that cannot be fully explained by tumor-intrinsic alterations alone. Emerging evidence suggests that immune cell senescence, particularly within B-cell compartments, may critically reshape the tumor immune microenvironment (TIME) and influence disease progression. However, the molecular determinants and clinical relevance of B-cell senescence in PTC remain poorly defined. The aim of this study was to identify B-cell senescence-related biomarkers and their clinical relevance in PTC. - Source: PubMed
Publication date: 2026/04/17
Liu TenghongChen ZhijunWu HongyiZhao Wenxin - Asthma imposes a significant global health burden; however, the mechanistic role of cellular senescence in its pathogenesis remains poorly defined. - Source: PubMed
Publication date: 2026/05/15
Lei LipingYao DongHuang JianweiWei JianghongMo Biwen - Autism spectrum disorder (ASD) is a neurodevelopmental disorder marked by repetitive behaviors and difficulties in social interaction and communication. The pathogenesis of ASD remains poorly understood, and no definitive treatment is currently available. This study aimed to systematically identify key genes and signaling pathways involved in autistic-like behaviors by performing genome-wide transcriptional profiling on a neonatal maternal separation (NMS) rat model, thereby revealing the underlying molecular mechanisms. - Source: PubMed
Publication date: 2026/04/28
Zhang QingMa JinhuaXu BoqingLi XiaohuanDai ChunfangZhu LiqiongDing Xiaoting - Migraine is a chronic neurological disorder. As a classic formula for promoting blood circulation and removing blood stasis, Xuefu Zhuyu Decoction (XFZYD) has shown definite clinical efficacy in the treatment of migraine with blood stasis syndrome; however, its biological mechanisms have not yet been fully elucidated and warrant further investigation. Therefore, in this study, we employed untargeted metabolomics, combined with transcriptomic sequencing, to identify endogenous differential metabolites in plasma and differentially expressed genes in brain tissue that were significantly regulated by XFZYD in migraine rats. We further explored the key targets and potential therapeutic mechanisms involved. Through integrated multi-omics analysis, the MAPK/ERK signaling pathway was ultimately identified as the key pathway regulated by XFZYD. Molecular biology experiments further confirmed that XFZYD modulated the expression of genes involved in inflammation, vascular function, and stress response within this pathway, acting on key genes such as COX-2, P-ERK1/2, Nr4a1, and Egr2, thereby intervening in two core pathological processes: vascular dysfunction and neurogenic inflammation. In summary, from both the transcriptomic and terminal metabolic levels, this study systematically elucidated the multidimensional mechanisms by which XFZYD treats migraine by reversing the "blood stasis" state and exerting its effect of "promoting blood circulation and removing blood stasis," thereby providing new research directions and a theoretical basis for its clinical application. - Source: PubMed
Publication date: 2026/04/26
Zhu Ting-TingWang Zhu-JunRen Ke-KeLiu Wen-DuanXiao Long-JinFeng Yu-LinYang Shi-LinOuyang Hui